Superiority of melphalan-prednisone (MP) + thalidomide (THAL) over MP or autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma (MM)

Reviewer: Charles Wood, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 5 de junio del 2006

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Thalidomide Not Linked to Better Lung Cancer Survival

Nov 26, 2015

Thrombotic events more likely in small cell lung cancer patients taking thalidomide than placebo

Thalidomide May Be Helpful in Recurrent Prostate Cancer

Nov 26, 2015

Drug associated with prostate specific antigen progression-free survival in men with biochemically recurrent cancer